Open Label, Phase I ZD6474 Head and Neck Cancer Study

NCT00450138 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: ZD6474 (vandetanib)
DRUG: Cisplatin
RADIATION: Radiation

Sponsor

Sanofi